310 related articles for article (PubMed ID: 19060462)
1. Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet's disease.
Köse O; Dinç A; Simşek I
Dermatology; 2009; 218(2):140-5. PubMed ID: 19060462
[TBL] [Abstract][Full Text] [Related]
2. Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial.
Chams-Davatchi C; Barikbin B; Shahram F; Nadji A; Moghaddassi M; Yousefi M; Davatchi F
Int J Rheum Dis; 2010 Aug; 13(3):253-8. PubMed ID: 20704623
[TBL] [Abstract][Full Text] [Related]
3. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus.
Gorouhi F; Solhpour A; Beitollahi JM; Afshar S; Davari P; Hashemi P; Nassiri Kashani M; Firooz A
J Am Acad Dermatol; 2007 Nov; 57(5):806-13. PubMed ID: 17658663
[TBL] [Abstract][Full Text] [Related]
5. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
Karabulut AA; Izol Serel B; Eksioglu HM
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
[TBL] [Abstract][Full Text] [Related]
6. A double-blind trial of depot corticosteroids in Behçet's syndrome.
Mat C; Yurdakul S; Uysal S; Gogus F; Ozyazgan Y; Uysal O; Fresko I; Yazici H
Rheumatology (Oxford); 2006 Mar; 45(3):348-52. PubMed ID: 16263779
[TBL] [Abstract][Full Text] [Related]
7. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
Lonsdale-Eccles AA; Velangi S
Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
[TBL] [Abstract][Full Text] [Related]
8. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study.
Volz T; Caroli U; Lüdtke H; Bräutigam M; Kohler-Späth H; Röcken M; Biedermann T
Br J Dermatol; 2008 Sep; 159(4):936-41. PubMed ID: 18647310
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses.
Akar A; Bülent Taştan H; Erbil H; Arca E; Kurumlu Z; Gür AR
J Dermatolog Treat; 2001 Dec; 12(4):199-203. PubMed ID: 12241628
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity assessment using comet assay in Behcet's disease patients.
Bilgici B; Bedir A; Sentürk N; Alvur M; Aydin F; Turanli AY
Mutat Res; 2005 Oct; 578(1-2):170-4. PubMed ID: 16019038
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival ulcers in Behçet's disease.
Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
[TBL] [Abstract][Full Text] [Related]
12. Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis.
Arabaci T; Kara C; Ciçek Y
J Periodontal Res; 2009 Dec; 44(6):718-25. PubMed ID: 19076988
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha treatment of Behçet's disease.
O'Duffy JD; Calamia K; Cohen S; Goronzy JJ; Herman D; Jorizzo J; Weyand C; Matteson E
J Rheumatol; 1998 Oct; 25(10):1938-44. PubMed ID: 9779847
[TBL] [Abstract][Full Text] [Related]
14. Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
Grayson PC; Yazici Y; Merideth M; Sen HN; Davis M; Novakovich E; Joyal E; Goldbach-Mansky R; Sibley CH
Arthritis Res Ther; 2017 Mar; 19(1):69. PubMed ID: 28335798
[TBL] [Abstract][Full Text] [Related]
15. [Esophageal involvement in Behçet's disease].
Martínez Salmerón JF; Gutiérrez-Rave Pecero V; Uariachi M; Ogea García JL; Franco Cebrián J; Castillo Higueras P
Rev Esp Enferm Dig; 1992 Sep; 82(3):187-8. PubMed ID: 1419316
[TBL] [Abstract][Full Text] [Related]
16. [Dermato-mucosal manifestations of Behçet's disease].
Francès C
Ann Med Interne (Paris); 1999 Nov; 150(7):535-41. PubMed ID: 10637669
[TBL] [Abstract][Full Text] [Related]
17. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
[TBL] [Abstract][Full Text] [Related]
18. [A case of Behçet's disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporin].
Fujii Y; Arimura Y; Takahashi N; Toki T; Marumo T; Yoshihara K; Nakabayashi K; Yamada A
Ryumachi; 2003 Feb; 43(1):44-50. PubMed ID: 12692989
[TBL] [Abstract][Full Text] [Related]
19. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.
Farajzadeh S; Daraei Z; Esfandiarpour I; Hosseini SH
Pediatr Dermatol; 2009; 26(3):286-91. PubMed ID: 19706089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
